案例展示

案例展示

Current: Home > Case > Development of Oligonucleotide Drug PCC

Development of Oligonucleotide Drug PCC

Biosyntech has an advanced nucleic acid drug technology platform and years of development experience, which can provide customers with comprehensive and highly specialized PCC molecule overall development services.




Next:None
  • menu

      

Wechat                       Wechat

Wechat

Address:Room 601, 6th Floor, Building 7, Area B, Phase IV, Suzhou Biomedical Industrial Park, 108 Huayun Road, Industrial Park, Suzhou City, Jiangsu Province

Phone:+86-0512-53980886

Email:order@bsyntech.com

Copyright © Suzhou Biosyntech Co., Ltd All rights reserved record number:Su ICP No. 2024107123-1 Mainly engaged insiRNA,Oligonucleotide,Small nucleic acids, Welcome to inquire!
Technical Support: Suzhou Biosyntech Disclaimers